BioCentury
ARTICLE | Clinical News

Oral hepatitis B vaccine: Began Phase I trial

July 12, 1999 7:00 AM UTC

Axis Genetics plc, Cambridge, U.K. Product: Oral hepatitis B vaccine Business: Infectious diseases Therapeutic category: Immune stimulation, Viral infection Target: HBV Description: Edible plant vacc...